Jonsson Comprehensive Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.cancer.ucla.edu

Clinical Trials

Improving Colonoscopy Surveillance for Patients with High Risk Colon Polyps

Not Applicable

Recruiting

Conditions: Colorectal Carcinoma

Interventions: Other: Interview
Other: Communication Intervention
Other: Best Practice

First Posted Date: 2024-04-19

Last Posted Date: 2024-10-30

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 1680

Registration Number: NCT06376565

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

A Vaccine (Neoantigen-Targeted ppDC) for the Treatment of H3 G34-mutant Diffuse Hemispheric Glioma

Phase 1

Recruiting

Conditions: Diffuse Hemispheric Glioma, H3 G34-Mutant

Interventions: Procedure: Biospecimen Collection
Biological: Dendritic Cell Therapy
Procedure: Leukapheresis
Procedure: Magnetic Resonance Imaging
Drug: Poly ICLC

First Posted Date: 2024-04-02

Last Posted Date: 2024-12-09

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 6

Registration Number: NCT06342908

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial

Phase 2

Recruiting

Conditions: Castration-Resistant Prostate Carcinoma
Stage IVB Prostate Cancer AJCC v8

Interventions: Procedure: Biospecimen Collection
Procedure: Computed Tomography
Other: Gallium Ga 68 Gozetotide
Drug: Lutetium Lu 177 Vipivotide Tetraxetan
Procedure: Positron Emission Tomography
Other: Questionnaire Administration
Procedure: Single Photon Emission Computed Tomography

First Posted Date: 2024-03-01

Last Posted Date: 2024-08-07

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 40

Registration Number: NCT06288113

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer

Phase 1

Not yet recruiting

Conditions: Colorectal Adenocarcinoma

Interventions: Drug: Fluoxetine

First Posted Date: 2024-01-25

Last Posted Date: 2024-06-24

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 10

Registration Number: NCT06225011

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)

Phase 2

Recruiting

Conditions: Prostate Carcinoma
Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8

Interventions: Procedure: Computed Tomography
Other: Gallium Ga 68 Gozetotide
Drug: Lutetium Lu 177 Vipivotide Tetraxetan
Procedure: Positron Emission Tomography
Procedure: PSMA PET Scan
Other: Questionnaire Administration
Procedure: Single Photon Emission Computed Tomography

First Posted Date: 2024-01-22

Last Posted Date: 2024-08-07

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 90

Registration Number: NCT06216249

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

Prevention of Frailty with Fisetin and Exercise (PROFFi) in Breast Cancer Survivors

Phase 2

Recruiting

Conditions: Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) V8
Anatomic Stage II Breast Cancer AJCC V8
Anatomic Stage III Breast Cancer AJCC V8
Early Stage Breast Carcinoma

Interventions: Procedure: Biospecimen Collection
Other: Educational Intervention
Other: Exercise Intervention
Drug: Fisetin
Other: Physical Performance Testing
Drug: Placebo Administration
Other: Quality-of-Life Assessment
Other: Questionnaire Administration

First Posted Date: 2023-11-02

Last Posted Date: 2024-12-20

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 164

Registration Number: NCT06113016

Locations: 🇺🇸
UCLA Health Cancer Care in Alhambra, Alhambra, California, United States
🇺🇸
UCLA Health Beverly Hills Primary & Specialty Care, Beverly Hills, California, United States
🇺🇸
UCLA Health Burbank Primary & Specialty Care, Burbank, California, United States

and more 3 locations

Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic Cancer

Not Applicable

Recruiting

Conditions: Stage III Pancreatic Cancer
Pancreatic Adenocarcinoma Non-resectable

Interventions: Other: Dietary Intervention
Other: Best Practice
Other: Medical Chart Review
Other: Medical Device Usage and Evaluation
Other: Nutritional Assessment
Other: Questionnaire Administration

First Posted Date: 2023-10-19

Last Posted Date: 2024-07-08

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 100

Registration Number: NCT06090916

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

Implementation Research to Increase Colorectal Cancer Screening Rates Among Low Income and Ethnic Minority Groups

Not Applicable

Active, not recruiting

Conditions: Colorectal Carcinoma

Interventions: Other: Best Practice
Other: Consultation
Other: Electronic Health Record Review
Other: Educational Intervention
Other: Fecal Immunochemical Test
Behavioral: Feedback
Behavioral: Health Education
Other: Support Education Activity
Other: Text Message-Based Navigation Intervention

First Posted Date: 2023-10-19

Last Posted Date: 2024-10-01

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 9745

Registration Number: NCT06090643

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma

Not Applicable

Recruiting

Conditions: Glioblastoma
Recurrent Glioblastoma
Resectable Glioblastoma

Interventions: Procedure: Biospecimen Collection
Procedure: Magnetic Resonance Imaging
Other: Medical Chart Review

First Posted Date: 2023-10-19

Last Posted Date: 2024-10-01

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 50

Registration Number: NCT06090903

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer

Early Phase 1

Completed

Conditions: Malignant Breast Neoplasm
Benign Breast Neoplasm
Breast Carcinoma

Interventions: Procedure: Diffusion Weighted Imaging
Procedure: Magnetic Resonance Spectroscopic Imaging

First Posted Date: 2023-10-19

Last Posted Date: 2024-04-17

Lead Sponsor: Jonsson Comprehensive Cancer Center

Target Recruit Count: 83

Registration Number: NCT06090630

Locations: 🇺🇸
UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy